Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Scientific News Boston Scientific Bsx Gains From Acquisitions, New Launches

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific Bsx Gains From Acquisitions, New Launches is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Scientific News Boston Scientific Bsx Gains From Acquisitions, New Launches | RobinsPost News & Noticias

Boston Scientific Q3: Operational Improvements Warrant An Upgrade To A Buy


Boston Scientific posts strong Q3 growth and upgrades 2025 outlook. See why BSX stock is rated Buy and what drives its leadership. Read More

What's Behind Boston Scientific's Optimism for Urology Growth?


Boston Scientific BSX delivered solid sales in the Urology franchise in the third quarter of 2025, growing 27% operationally and 5% organically. The business specializes in devices to treat various ... Read More

Boston Scientific Corporation (BSX) Q3 2025 Earnings Call Transcript


Good morning, and welcome to the Boston Scientific Third Quarter 2025 Earnings Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to ... Read More

Boston Scientific Gains Momentum As Growth Broadens, Goldman Sachs Says


The Boston Scientific Analyst: Analyst David Roman reiterated a Buy rating and price target of $120. The Boston Scientific Thesis: The company's total sales grew 20.3% year-on-year to around $5.1 ... Read More

Boston Scientific: Q3 Earnings Snapshot


MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Boston Scientific Corp. (BSX) on Wednesday reported third-quarter profit of $755 million. On a per-share basis, the Marlborough, Massachusetts-based ... Read More

Boston Scientific boosts chronic pain therapy portfolio with Nalu deal


Oct 17 (Reuters) - Medical device maker Boston Scientific (BSX.N), opens new tab said on Friday it will buy the remaining equity in privately held Nalu Medical for about $533 million in cash, ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus